Cargando…

Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling

Doxorubicin (Dox) is an effective chemotherapeutic agent used in the treatment of various cancers. Its clinical use is often limited due to its potentially fatal cardiotoxic side effect. Increasing evidence indicates that tumour protein p53 (p53), adenosine monophosphate-activated protein kinase (AM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Rabia, Shabalala, Samukelisiwe, Louw, Johan, Kappo, Abidemi Paul, Muller, Christo John Frederick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151817/ https://www.ncbi.nlm.nih.gov/pubmed/28937626 http://dx.doi.org/10.3390/molecules22101589

Ejemplares similares

Rooibos Flavonoids, Aspalathin, Isoorientin, and Orientin Ameliorate Antimycin A-Induced Mitochondrial Dysfunction by Improving Mitochondrial Bioenergetics in Cultured Skeletal Muscle Cells
por: Mthembu, Sinenhlanhla X. H., et al.
Publicado: (2021)

Intestinal Transport Characteristics and Metabolism of C-Glucosyl Dihydrochalcone, Aspalathin
por: Bowles, Sandra, et al.
Publicado: (2017)

The Transcription Profile Unveils the Cardio-Protective Effect of Aspalathin against Lipid Toxicity in an In Vitro H9c2 Model
por: Johnson, Rabia, et al.
Publicado: (2017)

Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression
por: Dludla, Phiwayinkosi V., et al.
Publicado: (2017)

Aspalathin, a natural product with the potential to reverse hepatic insulin resistance by improving energy metabolism and mitochondrial respiration
por: Mazibuko-Mbeje, Sithandiwe E., et al.
Publicado: (2019)

Aspalathin-Enriched Green Rooibos Extract Reduces Hepatic Insulin Resistance by Modulating PI3K/AKT and AMPK Pathways
por: Mazibuko-Mbeje, Sithandiwe E., et al.
Publicado: (2019)

Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice
por: Patel, Oelfah, et al.
Publicado: (2021)

RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway
por: Jiao, Yuheng, et al.
Publicado: (2022)

Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
por: Patel, Oelfah, et al.
Publicado: (2022)

Aspalathin-Rich Green Rooibos Extract Lowers LDL-Cholesterol and Oxidative Status in High-Fat Diet-Induced Diabetic Vervet Monkeys
por: Orlando, Patrick, et al.
Publicado: (2019)

Decision-making by p53 and mTOR
por: Maki, Carl G.
Publicado: (2010)

Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs
por: Patel, Oelfah, et al.
Publicado: (2016)

New Insights into the Efficacy of Aspalathin and Other Related Phytochemicals in Type 2 Diabetes—A Review
por: Muller, Christo J. F., et al.
Publicado: (2021)

The Combination Effect of Aspalathin and Phenylpyruvic Acid-2-O-β-d-glucoside from Rooibos against Hyperglycemia-Induced Cardiac Damage: An In Vitro Study
por: Dludla, Phiwayinkosi V., et al.
Publicado: (2020)

Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
por: McSweeney, K. Melodi, et al.
Publicado: (2019)

p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity
por: Venanzi, Franco M., et al.
Publicado: (2019)

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
por: Li, Weili, et al.
Publicado: (2022)

p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
por: Guo, Yuanfang, et al.
Publicado: (2023)

Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma
por: Negri, Mariarosaria, et al.
Publicado: (2022)

Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice
por: Mabasa, Lawrence, et al.
Publicado: (2022)

Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors
por: Pezzicoli, Gaetano, et al.
Publicado: (2021)

In vitro and in vivo hepatotoxicity study of Afriplex™ GRT through an inflammatory response
por: Gabuza, Kwazikwakhe B., et al.
Publicado: (2022)

Flavonoids from Hippophae rhamnoides Linn. Revert Doxorubicin-Induced Cardiotoxicity through Inhibition of Mitochondrial Dysfunction in H9c2 Cardiomyoblasts In Vitro
por: Zhou, Wenna, et al.
Publicado: (2023)

mTOR favors senescence over quiescence in p53-arrested cells
por: Schug, Thaddeus T.
Publicado: (2010)

p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
por: Akeno, Nagako, et al.
Publicado: (2014)

SYKT Alleviates Doxorubicin-Induced Cardiotoxicity via Modulating ROS-Mediated p53 and MAPK Signal Pathways
por: Chen, Ting, et al.
Publicado: (2018)

mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
por: Merle, David A., et al.
Publicado: (2021)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats
por: Shiromwar, Shruti S., et al.
Publicado: (2011)

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
por: Shen, Yihui, et al.
Publicado: (2022)

Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model
por: Al-Shabanah, Othman A., et al.
Publicado: (2012)

mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
por: Kon, Ning, et al.
Publicado: (2021)

Coordination of the AMPK, Akt, mTOR, and p53 Pathways under Glucose Starvation
por: Zhou, Yifan, et al.
Publicado: (2022)

Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2022)

Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis
por: Tan, Ye, et al.
Publicado: (2023)

p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway
por: Zhao, Jianlan, et al.
Publicado: (2021)

Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway
por: Yang, Yi, et al.
Publicado: (2019)

An In Vitro Study on the Combination Effect of Metformin and N-Acetyl Cysteine against Hyperglycaemia-Induced Cardiac Damage
por: Johnson, Rabia, et al.
Publicado: (2019)

Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis
por: Li, Weili, et al.
Publicado: (2022)

miR-499-5p Attenuates Mitochondrial Fission and Cell Apoptosis via p21 in Doxorubicin Cardiotoxicity
por: Wan, Qinggong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kmqki0usdn3b4gvtn4bc6ihnou